Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 2:20 pm Purchase |
2024-12-31 | 13G | Lyell Immunopharma, Inc. LYEL |
Foresite Capital Fund IV, L.P. | 19,478,893 6.700% |
5,795,035 (+42.35%) |
Filing History |
| 2025-02-07 4:01 pm Unchanged |
2025-01-31 | 13G | Maze Therapeutics, Inc. MAZE |
Foresite Capital Fund IV, L.P. | 2,457,108 5.600% |
0 (Unchanged) |
Filing History |
| 2025-02-07 4:01 pm Purchase |
2025-01-31 | 13G | Maze Therapeutics, Inc. MAZE |
Foresite Capital Fund IV, L.P. | 2,457,108 5.600% |
2,457,108 (New Position) |
Filing History |
| 2024-10-31 6:00 pm Purchase |
2024-10-25 | 13G | Lyell Immunopharma, Inc. LYEL |
Foresite Capital Fund IV, L.P. | 13,683,858 5.300% |
3,683,858 (+36.84%) |
Filing History |
| 2024-02-13 2:24 pm Sale |
2023-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS |
Foresite Capital Fund IV, L.P. | 0 0.000% |
-4,066,277 (Position Closed) |
Filing History |
| 2024-02-13 2:14 pm Purchase |
2023-12-31 | 13G | Pharvaris N.V. PHVS |
Foresite Capital Fund IV, L.P. | 4,038,842 7.800% |
757,774 (+23.10%) |
Filing History |
| 2023-05-10 5:20 pm Purchase |
2023-05-08 | 13D | Kinnate Biopharma Inc. KNTE |
Foresite Capital Fund IV, L.P. | 13,718,311 29.500% |
1,780,000 (+14.91%) |
Filing History |
| 2023-02-22 3:01 pm Purchase |
2023-02-17 | 13D | Kinnate Biopharma Inc. KNTE |
Foresite Capital Fund IV, L.P. | 11,938,311 25.600% |
1,100,000 (+10.15%) |
Filing History |
| 2023-02-13 5:06 pm Purchase |
2022-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS |
Foresite Capital Fund IV, L.P. | 4,066,277 6.100% |
4,066,277 (New Position) |
Filing History |
| 2023-02-13 5:02 pm Sale |
2022-12-31 | 13G | Lyell Immunopharma, Inc. LYEL |
Foresite Capital Fund IV, L.P. | 10,000,000 4.000% |
-3,282,181 (-24.71%) |
Filing History |
| 2023-02-13 4:56 pm Sale |
2022-12-31 | 13G | Pharvaris N.V. PHVS |
Foresite Capital Fund IV, L.P. | 3,281,068 9.700% |
-15,000 (-0.46%) |
Filing History |
| 2022-06-28 12:37 pm Sale |
2022-06-17 | 13D | Quantum-Si incorporated QSI |
Foresite Capital Fund IV, L.P. | 4,424,317 3.700% |
-4,000,000 (-47.48%) |
Filing History |
| 2022-02-11 3:13 pm Sale |
2021-12-31 | 13G | Keros Therapeutics, Inc. KROS |
Foresite Capital Fund IV, L.P. | 0 0.000% |
-1,412,705 (Position Closed) |
Filing History |
| 2022-02-11 3:12 pm Sale |
2021-12-31 | 13G | Pharvaris N.V. PHVS |
Foresite Capital Fund IV, L.P. | 3,296,068 9.900% |
-630,000 (-16.05%) |
Filing History |
| 2022-02-11 3:11 pm Sale |
2021-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Foresite Capital Fund IV, L.P. | 1,205,798 2.700% |
-2,045,051 (-62.91%) |
Filing History |
| 2022-02-11 3:10 pm Purchase |
2021-12-31 | 13G | Lyell Immunopharma, Inc. LYEL |
Foresite Capital Fund IV, L.P. | 13,282,181 5.500% |
13,282,181 (New Position) |
Filing History |
| 2021-06-21 5:20 pm Purchase |
2021-06-10 | 13D | Quantum-Si incorporated QSI |
Foresite Capital Fund IV, L.P. | 8,424,317 7.200% |
8,424,317 (New Position) |
Filing History |
| 2021-02-16 11:16 am Sale |
2020-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC |
Foresite Capital Fund IV, L.P. | 0 0.000% |
-1,500,000 (Position Closed) |
Filing History |
| 2021-02-16 11:08 am Purchase |
2020-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Foresite Capital Fund IV, L.P. | 3,250,849 8.400% |
90,065 (+2.85%) |
Filing History |
| 2021-02-16 10:56 am Sale |
2020-12-31 | 13G | Keros Therapeutics, Inc. KROS |
Foresite Capital Fund IV, L.P. | 1,412,705 6.100% |
-15,366 (-1.08%) |
Filing History |